Supernus Pharmaceuticals
SUPN
#5124
Rank
HK$13.57 B
Marketcap
HK$233.12
Share price
1.78%
Change (1 day)
-33.30%
Change (1 year)

EPS for Supernus Pharmaceuticals (SUPN)

EPS in 2026 (TTM): -HK$5.95

According to Supernus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$5.96. In 2025 the company made an earnings per share (EPS) of -HK$5.33 a decrease over its 2024 EPS that were of HK$10.51.

EPS history for Supernus Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$5.9511.64%
2025-HK$5.33-150.75%
2024HK$10.51
2022HK$8.8610.78%
2021HK$8.00-57.68%
2020HK$18.9012.09%
2019HK$16.860.47%
2018HK$16.7989.38%
2017HK$8.86-38.59%
2016HK$14.43534.48%
2015HK$2.27-211.54%
2014-HK$2.04-91.1%
2013-HK$22.9039.46%
2012-HK$16.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.40-978.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$21.21-455.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$242.30-4,164.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$35.45-694.74%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
HK$224.41-3,864.47%๐Ÿ‡บ๐Ÿ‡ธ USA